Strata Skin Sciences Share Price (NASDAQ: SSKN)

$2.38

▲

0.35

(17.24%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Strata Skin Sciences Stock chart to analyse performance

Strata Skin Sciences stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$2.05
Today's High:$2.58
$2.38
13.87%
Downside
Day's Volatility :20.54%
Upside
7.75%
52 Weeks Low:$1.61
52 Weeks High:$3.76
$2.38
32.35%
Downside
52 Weeks Volatility :57.18%
Upside
36.7%

Strata Skin Sciences Stock Returns

Period	Strata Skin Sciences Inc.	Index (Russel 2000)
3 Months	-1.34%	0.0%
6 Months	-7.2%	0.0%
1 Year	-23.79%	0.0%
3 Years	-75.25%	-4.7%

Strata Skin Sciences Inc. Key Stats

Check Strata Skin Sciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$2.03
Open	$2.16
Today's High	$2.58
Today's Low	$2.05
Market Capitalization	$8.8M
Today's Volume	$4.4M
52 Week High	$3.76
52 Week Low	$1.61
Revenue TTM	$32.8M
EBITDA	$-1.4M
Earnings Per Share (EPS)	$-2.84
Profit Margin	-35.13%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-235.41%

Stock Returns calculator for Strata Skin Sciences Stock including INR - Dollar returns

The Strata Skin Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Strata Skin Sciences investment value today

Current value as on today

₹79,197

Returns

₹20,803

(-20.8%)

Returns from Strata Skin Sciences Stock

₹26,087 (-26.09%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Strata Skin Sciences Stock

320%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Strata Skin Sciences Stock from India on INDmoney has increased by 320% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Strata Skin Sciences Inc.

Name
Holdings %
Name
Holdings %
22NW, LP
12.87%
Nantahala Capital Management, LLC
9.68%
Renaissance Technologies Corp
2.44%
Vanguard Group Inc
2.03%
Citadel Advisors Llc
0.69%
Geode Capital Management, LLC
0.44%

Analyst Recommendation on Strata Skin Sciences Stock

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Strata Skin Sciences(by analysts ranked 0 to 5 stars)

Strata Skin Sciences Share Price Target

What analysts predicted

Upside of 236.13%

Target:

$8.00

Current:

$2.38

Strata Skin Sciences share price target is $8.00, a slight Upside of 236.13% compared to current price of $2.38 as per analysts' prediction.

Strata Skin Sciences Stock Insights

Price Movement
In the last 7 days, SSKN stock has moved up by 40.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 6.81M → 7.66M (in $), with an average increase of 11.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -2.43M → -2.48M (in $), with an average decrease of 2.3% per quarter
SSKN vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 58.3%
SSKN vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 238.8%
Price to Sales
ForSSKN every $1 of sales, investors are willing to pay $0.3, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Strata Skin Sciences Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$31.6M	↑ 5.8%
Net Income	$-3.8M	↓ 6.03%
Net Profit Margin	-12.0%	↑ 1.51%

	FY20	Y/Y Change
Revenue	$23.1M	↓ 26.9%
Net Income	$-4.4M	↑ 16.41%
Net Profit Margin	-19.11%	↓ 7.11%

	FY21	Y/Y Change
Revenue	$30.0M	↑ 29.83%
Net Income	$-2.7M	↓ 38.67%
Net Profit Margin	-9.03%	↑ 10.08%

	FY22	Y/Y Change
Revenue	$36.2M	↑ 20.63%
Net Income	$-5.5M	↑ 105.06%
Net Profit Margin	-15.35%	↓ 6.32%

	FY23	Y/Y Change
Revenue	$33.4M	↓ 7.75%
Net Income	$-10.8M	↑ 95.17%
Net Profit Margin	-32.47%	↓ 17.12%

	FY24	Y/Y Change
Revenue	$33.6M	↑ 0.61%
Net Income	$-10.1M	↓ 6.87%
Net Profit Margin	-30.05%	↑ 2.42%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$6.8M	↓ 22.27%
Net Income	$-3.4M	↓ 11.23%
Net Profit Margin	-49.87%	↓ 6.21%

	Q2 FY24	Q/Q Change
Revenue	$8.4M	↑ 24.89%
Net Income	$-99.0K	↓ 97.06%
Net Profit Margin	-1.17%	↑ 48.7%

	Q3 FY24	Q/Q Change
Revenue	$8.8M	↑ 4.29%
Net Income	$-2.1M	↑ 2043.43%
Net Profit Margin	-24.12%	↓ 22.95%

	Q4 FY24	Q/Q Change
Revenue	$9.6M	↑ 8.86%
Net Income	$-4.5M	↑ 111.92%
Net Profit Margin	-46.96%	↓ 22.84%

	Q1 FY25	Q/Q Change
Revenue	$6.8M	↓ 28.86%
Net Income	$-2.4M	↓ 45.92%
Net Profit Margin	-35.7%	↑ 11.26%

	Q2 FY25	Q/Q Change
Revenue	$7.7M	↑ 12.49%
Net Income	$-2.5M	↑ 2.34%
Net Profit Margin	-32.48%	↑ 3.22%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$20.3M	↑ 18.4%

	FY20	Y/Y Change
Profit	$14.1M	↓ 30.27%

	FY21	Y/Y Change
Profit	$19.9M	↑ 40.44%

	FY22	Y/Y Change
Profit	$21.8M	↑ 9.66%

	FY23	Y/Y Change
Profit	$18.5M	↓ 15.19%

	FY24	Y/Y Change
Profit	$19.1M	↑ 3.36%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$3.1M	↓ 35.85%

	Q2 FY24	Q/Q Change
Profit	$4.9M	↑ 60.29%

	Q3 FY24	Q/Q Change
Profit	$5.3M	↑ 7.49%

	Q4 FY24	Q/Q Change
Profit	$5.8M	↑ 8.48%

	Q1 FY25	Q/Q Change
Profit	$3.6M	↓ 36.65%

	Q2 FY25	Q/Q Change
Profit	$4.3M	↑ 18.07%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$2.2M	↓ 23.03%
Investing Cash Flow	$-2.8M	↑ 56.36%
Financing Cash Flow	$-296.0K	↓ 102.62%

	FY20	Y/Y Change
Operating Cash Flow	$2.1M	↓ 5.97%
Investing Cash Flow	$-2.2M	↓ 22.64%
Financing Cash Flow	$2.5M	↓ 960.14%

	FY21	Y/Y Change
Operating Cash Flow	$1.5M	↓ 28.05%
Investing Cash Flow	$-7.1M	↑ 230.06%
Financing Cash Flow	$92.0K	↓ 96.39%

	FY22	Y/Y Change
Operating Cash Flow	$-1.1M	↓ 173.47%
Investing Cash Flow	$-4.2M	↓ 41.3%
Financing Cash Flow	$-500.0K	↓ 643.48%

	FY23	Y/Y Change
Operating Cash Flow	$-519.0K	↓ 53.16%
Investing Cash Flow	$-5.0M	↑ 19.99%
Financing Cash Flow	$6.9M	↓ 1472.2%

	FY24	Y/Y Change
Operating Cash Flow	$188.0K	↓ 136.22%
Investing Cash Flow	$-1.6M	↓ 67.4%
Financing Cash Flow	$1.9M	↓ 71.94%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-804.0K	↓ 153.39%
Investing Cash Flow	$-725.0K	↓ 60.87%
Financing Cash Flow	$-18.0K	↓ 99.74%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$591.0K	↓ 173.51%
Investing Cash Flow	$-345.0K	↓ 52.41%
Financing Cash Flow	$0.0	↓ 100.0%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-302.0K	↓ 151.1%
Investing Cash Flow	$-62.0K	↓ 82.03%
Financing Cash Flow	$1.9M	-

	Q4 FY24	Q/Q Change
Operating Cash Flow	$703.0K	↓ 332.78%
Investing Cash Flow	$-504.0K	↑ 712.9%
Financing Cash Flow	$0.0	↓ 100.0%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-550.0K	↓ 178.24%
Investing Cash Flow	$-199.0K	↓ 60.52%
Financing Cash Flow	$-1.9M	-

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-1.9M	↑ 252.91%
Investing Cash Flow	$61.0K	↓ 130.65%
Financing Cash Flow	$0.0	↓ 100.0%

Strata Skin Sciences Technicals Summary

Sell

Neutral

Buy

Strata Skin Sciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Strata Skin Sciences Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Strata Skin Sciences Inc.	25.64%	-7.2%	-23.79%	-75.25%	-83.77%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Strata Skin Sciences Inc.	NA	NA	-0.02	-1.18	-2.35	-0.11	NA	0.07
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Strata Skin Sciences Inc.	Buy	$8.8M	-83.77%	NA	-35.13%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Strata Skin Sciences Inc.

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.

Organization	Strata Skin Sciences
Employees	106
CEO	Dr. Dolev Rafaeli Ph.D.
Industry	Health Technology

Key Management of Strata Skin Sciences Inc.

Name	Title
Dr. Dolev Rafaeli Ph.D.	President, CEO & Vice-Chairman
Mr. John Gillings	Principal Financial Officer & Chief Accounting Officer
Mr. Shmuel Gov	Chief Operating Officer
Mr. Jay Sturm	General Counsel & Corporate Secretary
Mr. Michael R. Stewart	Independent Consultant

Important FAQs about investing in SSKN Stock from India :

What is Strata Skin Sciences share price today?

Strata Skin Sciences share price today is $2.38 as on August 30, 2025 at 1:29 am IST at the close of the market. Strata Skin Sciences share today touched a day high of $2.58 and a low of $2.05.

What is the 52 week high and 52 week low for Strata Skin Sciences share?

Strata Skin Sciences share touched a 52 week high of $3.76 and a 52 week low of $1.61. Strata Skin Sciences stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $2.38, lower by 36.7% versus the 52 week high.

How to invest in Strata Skin Sciences Stock (SSKN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Strata Skin Sciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Strata Skin Sciences Shares that will get you 0.6303 shares as per Strata Skin Sciences share price of $2.38 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Strata Skin Sciences Stock (SSKN) from India?

Indian investors can start investing in Strata Skin Sciences (SSKN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Strata Skin Sciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Strata Skin Sciences share’s latest price of $2.38 as on August 30, 2025 at 1:29 am IST, you will get 4.2017 shares of Strata Skin Sciences. Learn more about fractional shares .

What are the returns that Strata Skin Sciences has given to Indian investors in the last 5 years?

Strata Skin Sciences stock has given -83.77% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?